Suchergebnisse - "Tjan-Heijnen, Vivianne C G"

PubPharm (333)

81

Additional Breast Cancer Detection at Digital Screening Mammography through Quality Assurance Sessions between Technologists and Radiologists

enthalten in: Radiology | 2020

von Coolen, A. | Korte, B. | Tjan-Heijnen, V. | +3

82

Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial

enthalten in: Breast cancer research and treatment | 2020

von van Hellemond, I. | Smorenburg, C. | Peer, P. | +13

83

Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial

enthalten in: Breast cancer research and treatment | 2020

von van Hellemond, I. | Smorenburg, C. | Peer, P. | +13

84

Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial

enthalten in: Breast cancer research and treatment | 2020

von van Hellemond, I. | Smorenburg, C. | Peer, P. | +13

85

The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancer

enthalten in: Breast cancer research and treatment | 2020

von Claessens, A. | Timman, R. | Busschbach, J. | +6

86

Variability of cost trajectories over the last year of life in patients with advanced breast cancer in the Netherlands

enthalten in: PloS one | 2020

von Schneider, P. | Pouwels, X. | Passos, V. | +11

87

Quality of life in a real-world cohort of advanced breast cancer patients : a study of the SONABRE Registry

Erschienen: 2020

von Claessens, A. | Ramaekers, B. | Lobbezoo, D. | +7

88

The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancer

enthalten in: Breast cancer research and treatment | 2019

von Claessens, A. | Timman, R. | Busschbach, J. | +5

89

The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancer

enthalten in: Breast cancer research and treatment | 2019

von Claessens, A. | Timman, R. | Busschbach, J. | +5

90

The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancer

enthalten in: Breast cancer research and treatment | 2019

von Claessens, A. | Timman, R. | Busschbach, J. | +5